Biotransformation of ellipticine into 5-formyl ellipticine by Choisya ternata strains

descriptionPublicationkeyboard_double_arrow_right Article 01 Oct 1984 English Publisher:Springer Science and Business Media LLCJournal:Plant Cell Reports, volume 3, pages 203-205 (issn: 0721-7714, eissn: 1432-203X,

Copyright policy )

Authors: K, Kouadio; M, Rideau; C, Ganser; J C, Chénieux; C, Viel;

doi: 10.1007/bf00270201

pmid: 24253517

Biotransformation of ellipticine into 5-formyl ellipticine by Choisya ternata strains

- Summary
- Metrics

Abstract

Sixteen Choisya ternata strains of same genotypic origin were examined for their capacities to biotransform ellipticine. Four strains were able to convert the drug into 5-formylellipticine with good yields. The reaction occurred only in agar medium and was different from ellipticine bioconversion by microorganisms or mammals.

Related Organizations

Centre national de la recherche scientifique
France

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	15
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%